Dr. House vs MyStart: Compare GLP-1 Programs & Pricing
Side-by-side Dr. House and MyStart: semaglutide/tirzepatide starting prices, promos, membership rules, and official links.
Dr. House and MyStart are two established telehealth providers offering GLP-1–based weight management programs. This article compares Dr. House vs MyStart to help you identify which best fits your goals and preferences.
Visit Dr. House
Explore MyStart
Dr. House vs MyStart: Quick Overview
| Provider | Semaglutide | Tirzepatide | Promo | Membership |
|---|---|---|---|---|
| Dr. House | Not listed | Not listed | — (Code: —) | — No |
| MyStart | $179.00 | $299.00 | — (Code: EXPLORE2026) | — |
Dr. House vs MyStart: Medical Process & Accessibility
Dr. House focuses on a fast telehealth intake workflow and clinician approval, often used by patients seeking quick onboarding. MyStart emphasizes structured follow-ups and ongoing dose adjustments through regular clinician check‑ins. Both operate under U.S. telehealth rules and require a clinical evaluation and prescription before any GLP‑1 medication is dispensed.
Dr. House vs MyStart: Pricing Comparison
Dr. House does not list public starting prices for semaglutide or tirzepatide on the information provided here. MyStart lists semaglutide from $179.00 and tirzepatide from $299.00. Where a provider does not publish a starting price, that typically means pricing may vary by individualized treatment plan, dosage, or pharmacy sourcing.
Please note that all prices shown are starting or promotional figures and may exclude shipping, clinician consultation fees, lab work, or pharmacy dispensing charges. Before enrolling, confirm total out‑of‑pocket cost with each provider and ask whether membership or subscription fees apply.
Dr. House vs MyStart: Clinical Oversight & Support
Both providers connect patients with licensed clinicians who perform medical screening, review histories, and approve prescriptions when appropriate. Telehealth providers must follow state and federal regulations: patients are evaluated for contraindications, pregnancy, or existing conditions that make GLP‑1s unsafe. Neither platform replaces in‑person emergency care.
MyStart highlights ongoing dose optimization and scheduled follow‑ups; Dr. House emphasizes speed and accessibility of initial appointments. Ask each provider about the frequency of follow‑ups, access to clinicians between visits, and any included educational resources.
Book a Consultation with Dr. House
Dr. House vs MyStart: Medication Quality & Safety
Both companies dispense prescription GLP‑1 therapies through accredited U.S. pharmacies. Some offerings are compounded alternatives and are not identical to FDA‑approved branded products such as Wegovy® (semaglutide), Ozempic® (semaglutide), or Mounjaro® (tirzepatide). Compounded products are legal when prescribed by a clinician, but formulations can differ in inactive ingredients and dosing presentation.
All GLP‑1 medications are prescription only. FDA‑compliant telehealth care includes screening for contraindications, informed consent, and education on side effects like nausea, pancreatitis risk symptoms, and hypoglycemia when combined with other diabetes medications. Always report adverse effects to your clinician promptly.
Dr. House vs MyStart: Customer Experience
Customer reports generally note that Dr. House is convenient and oriented toward affordability, while MyStart is frequently praised for attentive clinical follow‑up and communication. Shipping windows vary but many patients receive medication within about one week of prescription approval; confirm expected turnaround during intake.
When choosing, weigh speed and price against the level of medical monitoring you prefer. If you have complex medical history, prioritize platforms that offer thorough follow‑up and easy clinician access.
Join Dr. House
Get Started with MyStart
Dr. House vs MyStart: Final Verdict
Choose Dr. House if you prioritize rapid onboarding and potential low‑cost options where posted; choose MyStart if you value structured clinical oversight and transparent starting prices ($179.00 semaglutide, $299.00 tirzepatide) with a visible promo code (EXPLORE2026).
Disclaimer
This article is for informational purposes only and does not constitute medical advice. All GLP‑1 medications require a prescription and clinical evaluation. ExploreProviders may receive affiliate commissions at no cost to you. Always consult a licensed clinician before beginning any medical treatment and follow FDA guidance and the prescribing provider’s instructions.
Starts at $146/mo (6‑month plan)
- Affordable Semaglutide injections
- Klarna / AfterPay / Affirm supported
- Personalized dosing to reach goals
From $179 + free FedEx
- Approval within ~4 hours*
- Semaglutide & Tirzepatide available
- Price‑lock: same price any dose
Free consult ($75 value)
- GLP‑1 ID Protocol — 46% faster*
- 4.9★ Google & Trustpilot
- No‑obligation evaluation
$120 OFF First Month
- GLP‑1 meds delivered to your door
- Refund if you don’t lose weight
- Doctor‑approved, U.S. clinicians
Save $70 (Code: Explore)
- Ozempic®, Tirzepatide & Semaglutide
- Instant approval, ship ≤ 3 days
- No membership fees
From $155/mo (12‑month plan)
- No insurance or membership required
- Quick approval — no waitlist
- Brand & compounded available
$50 Off First Month
- 2‑minute quiz, $50 off month one
- Prescription in ≤ 24 hours
- Cancel or change anytime
Pay $199 first month
- Free overnight shipping
- Avg. 14% weight loss*
- No insurance needed
$120 OFF First Month
- Affordable access to treatments
- Doctor‑supervised programs
- Clear pricing
$50 OFF First Month
- Streamlined treatment process
- Holistic program
- Mobile‑friendly platform
.png)
Programs available
- 100% online evaluation
- Provider messaging & check‑ins
- Fast‑track programs
From $249 / month
- Certified GLP‑1 providers
- Licensed consultations
- Nationwide coverage